课题基金 / 基金详情

Clinical and Translational Science Institute at Children's National

Clinical and Translational Science Institute at Children's National
国家儿童医院临床与转化科学研究所
批准号:
8722060
负责人:
LISA MARIE GUAY-WOODFORD
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2016-03-31

项目摘要

项目成果

LISA MARIE GUAY-WOODFORD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Joseph, JIN G. After a decade of remarkable research growth and institutional investment. Children's National Medical Center (CNMC) builds on significant strategic recruitments, reorganizations, and collaborations required to create the transformative capabilities of the Clinical and Translational Science Institute at Children's National (CTSI-CN). It has done so in partnership with its academic affiliate, the George Washington University. The specific objectives of our application are to: 1) Provide state-of-the-art, flexible resources required by CTR investigators; 2) Promote multidisciplinary clinical and translational research (CTR); 3) Strengthen CTR education and training for diverse trainees at all stages of career development; 4) Promote demographic diversity and address health disparities; 5) Incorporate effective and sustained collaboration with community partners; 6) Assure efficiency of CTR from conceptualization through dissemination; and 7) Establish bi-directional collaborations with the CTSA network. The CTSI-CN has innovative features including: a child health focus, especially emphasizing health disparities and childhood antecedents of adult diseases; our relationship with a national network of 1200 community health centers, and in Tl strengths in rare diseases and neurodevelopmental disabilities. We have combined certain related CTSA components to provide more closely integrated, investigator-focused capabilities. Biomedical Informatics (Bl): provides the backbone informatics support to all CTSI-CN components. Research Education, Training and Career Development (RETCD) integrates, supports, and expands CTR education and training so that it is available from high school through mid-career. A new degree program (MS in CTR) and a certificate program are complemented by diverse educational opportunities for faculty, trainees, and staff at all levels of experience. Specialized programs are available for mid-level faculty to promote their career advancement and mentoring capabilities, and for underrepresented minority undergraduates potentially interested in a career in CTR. Community Engagement and Research/Health Policy (CER/HP) integrates traditional community engagement/research with nationally recognized health policy capabilities. Participant and Clinical Interactions Resources (PCIR) transforms our existing GCRC into a nimble and innovative resource that supports participant interactions at diverse locations including CNMC, outpatient facilities, GW, and the community. Pilot and Collaborative Translational and Clinical Studies: supports transfomnative ideas by investigators at all career levels. Novel Clinical and Translational Methodologies (NCTM) identifies needs and gaps and supports development of innovative methodologies, especially to support TTR cores. Research Design. Epidemiology. Biostatistics, and Clinical Research Ethics/Regulatory Knowledge and Support (DBE/RKS): provides integrated, investigator-focused resources to assure the quality of research and the protection of human subjects at all stages of research. Translational Technologies and Resources (TTR) supports a diverse group of 15 core functions. Tracking and Evaluation (TE): CTSI-CN activities will be guided and modified by a thoughtful and detailed evaluation plan. RELEVANCE (See instructions): The CTSI-CN provides highly integrated, cost effective, investigator-focused resources designed to overcome obstacles to investigation, promote collaborative research, and be continuously monitored and evaluated to identify when further adaptation or modification is needed. Located in the nation's capital and serving a population of children and families disproportionately affected by health disparities, the CTSI-CN brings to bear unique resources in translating discovery to improved health, particularly in our most disadvantaged populations of children.
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/acm.0000000000000073
发表时间: 2014-01
期刊: Academic medicine : journal of the Association of American Medical Colleges
影响因子: --
作者: [Nishijima DK, Dinh T, May L, Yadav K, Gaddis GM, Cone DC]
通讯作者: Cone DC
DOI: 10.1186/s12920-018-0340-3
发表时间: 2018-02-27
期刊: BMC medical genomics
影响因子: 2.7
作者: [Gomez JL, Diaz MP, Nino G, Britto CJ]
通讯作者: Britto CJ
DOI: 10.1371/journal.pone.0162244
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者: [Gutierrez MJ, Gomez JL, Perez GF, Pancham K, Val S, Pillai DK, Giri M, Ferrante S, Freishtat R, Rose MC, Preciado D, Nino G]
通讯作者: Nino G
Semi-automatic segmentation of the placenta into fetal and maternal compartments using intravoxel incoherent motion MRI.
使用体素内不相干运动 MRI 将胎盘半自动分割为胎儿和母体区室。
DOI: 10.1117/12.2254610
发表时间: 2017
期刊: Proceedings of SPIE--the International Society for Optical Engineering
影响因子: --
作者: [You,Wonsang, Andescavage,Nickie, Zun,Zungho, Limperopoulos,Catherine]
通讯作者: Limperopoulos,Catherine
29
    UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC) - Clinical, Translational, and Biorepository Resource
    • 批准号:
      10455719
    • 项目类别:
    • 资助金额:
      $14.14万
    • 财政年份:
      2020
    • 负责人:
      LISA MARIE GUAY-WOODFORD
    • 依托单位:
    Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
    • 批准号:
      10170340
    • 项目类别:
    • 资助金额:
      $39.27万
    • 财政年份:
      2020
    • 负责人:
      LISA MARIE GUAY-WOODFORD
    • 依托单位:
    UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC) - Clinical, Translational, and Biorepository Resource
    • 批准号:
      10685977
    • 项目类别:
    • 资助金额:
      $15.47万
    • 财政年份:
      2020
    • 负责人:
      LISA MARIE GUAY-WOODFORD
    • 依托单位:
    Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
    • 批准号:
      10382438
    • 项目类别:
    • 资助金额:
      $39.27万
    • 财政年份:
      2020
    • 负责人:
      LISA MARIE GUAY-WOODFORD
    • 依托单位:
    海外基金